| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Insulin Resistance | 94 | 2024 | 406 | 11.680 |
Why?
|
| Obesity | 59 | 2024 | 1191 | 4.410 |
Why?
|
| Liver | 52 | 2024 | 788 | 4.360 |
Why?
|
| Insulin | 75 | 2023 | 688 | 4.110 |
Why?
|
| Glucose | 58 | 2023 | 447 | 4.060 |
Why?
|
| Diet, High-Fat | 32 | 2024 | 159 | 3.350 |
Why?
|
| Muscle, Skeletal | 36 | 2021 | 678 | 3.080 |
Why?
|
| Mice | 146 | 2024 | 10331 | 2.350 |
Why?
|
| Adipose Tissue | 28 | 2019 | 284 | 2.200 |
Why?
|
| Mice, Knockout | 63 | 2024 | 1998 | 2.200 |
Why?
|
| Inflammation | 20 | 2021 | 1111 | 2.120 |
Why?
|
| Energy Metabolism | 33 | 2022 | 351 | 2.030 |
Why?
|
| Dietary Fats | 22 | 2020 | 204 | 2.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 18 | 2022 | 673 | 1.840 |
Why?
|
| Animals | 155 | 2024 | 19752 | 1.800 |
Why?
|
| Adipocytes | 26 | 2023 | 253 | 1.800 |
Why?
|
| Mice, Inbred C57BL | 69 | 2024 | 3220 | 1.790 |
Why?
|
| Fatty Liver | 13 | 2024 | 96 | 1.660 |
Why?
|
| Glucose Clamp Technique | 28 | 2021 | 58 | 1.580 |
Why?
|
| Interleukin-10 | 4 | 2016 | 147 | 1.540 |
Why?
|
| Signal Transduction | 40 | 2024 | 2892 | 1.530 |
Why?
|
| Macrophages | 11 | 2024 | 1015 | 1.520 |
Why?
|
| Leptin | 8 | 2016 | 78 | 1.270 |
Why?
|
| Myocardium | 11 | 2016 | 263 | 1.260 |
Why?
|
| Glucose Intolerance | 16 | 2021 | 88 | 1.180 |
Why?
|
| Blood Glucose | 26 | 2018 | 473 | 0.960 |
Why?
|
| Hyperinsulinism | 12 | 2022 | 24 | 0.950 |
Why?
|
| Adipose Tissue, White | 13 | 2022 | 82 | 0.910 |
Why?
|
| Interleukin-12 | 1 | 2024 | 122 | 0.890 |
Why?
|
| Adipose Tissue, Brown | 9 | 2022 | 100 | 0.880 |
Why?
|
| Male | 80 | 2024 | 27963 | 0.880 |
Why?
|
| Carcinoembryonic Antigen | 6 | 2021 | 33 | 0.850 |
Why?
|
| Mice, Transgenic | 31 | 2022 | 1226 | 0.830 |
Why?
|
| Fatty Acids | 16 | 2021 | 194 | 0.830 |
Why?
|
| Receptor, Insulin | 8 | 2022 | 48 | 0.790 |
Why?
|
| Lipogenesis | 7 | 2022 | 65 | 0.790 |
Why?
|
| Interferon-gamma | 1 | 2024 | 550 | 0.780 |
Why?
|
| Heat-Shock Proteins | 4 | 2018 | 66 | 0.780 |
Why?
|
| Homeostasis | 21 | 2021 | 343 | 0.780 |
Why?
|
| Thermogenesis | 9 | 2023 | 108 | 0.780 |
Why?
|
| AMP-Activated Protein Kinases | 7 | 2021 | 65 | 0.770 |
Why?
|
| Transcription Factors | 13 | 2019 | 1459 | 0.750 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2021 | 6 | 0.740 |
Why?
|
| Liver Diseases | 1 | 2021 | 136 | 0.660 |
Why?
|
| Disease Models, Animal | 17 | 2022 | 2078 | 0.660 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2021 | 164 | 0.640 |
Why?
|
| Interleukin-6 | 8 | 2018 | 309 | 0.630 |
Why?
|
| Aging | 5 | 2020 | 731 | 0.630 |
Why?
|
| Body Composition | 12 | 2020 | 155 | 0.620 |
Why?
|
| Hyperglycemia | 5 | 2022 | 104 | 0.580 |
Why?
|
| Iodide Peroxidase | 3 | 2016 | 23 | 0.580 |
Why?
|
| Stress, Physiological | 6 | 2020 | 186 | 0.570 |
Why?
|
| Cells, Cultured | 18 | 2020 | 2101 | 0.570 |
Why?
|
| Lipid Metabolism | 9 | 2021 | 203 | 0.550 |
Why?
|
| Adiposity | 9 | 2020 | 78 | 0.540 |
Why?
|
| Gene Expression Regulation | 14 | 2021 | 1538 | 0.530 |
Why?
|
| Heart Diseases | 2 | 2011 | 206 | 0.530 |
Why?
|
| Heart | 6 | 2016 | 276 | 0.520 |
Why?
|
| TRPM Cation Channels | 2 | 2013 | 15 | 0.490 |
Why?
|
| Interleukin-2 | 1 | 2015 | 164 | 0.490 |
Why?
|
| Phosphorylation | 18 | 2020 | 860 | 0.490 |
Why?
|
| TRPV Cation Channels | 1 | 2015 | 17 | 0.490 |
Why?
|
| Lymphocytes | 1 | 2015 | 194 | 0.480 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 516 | 0.460 |
Why?
|
| Carrier Proteins | 5 | 2020 | 704 | 0.440 |
Why?
|
| Adipokines | 6 | 2022 | 28 | 0.440 |
Why?
|
| Ventricular Dysfunction | 1 | 2013 | 10 | 0.440 |
Why?
|
| Diabetes Mellitus, Experimental | 4 | 2020 | 194 | 0.430 |
Why?
|
| Body Weight | 12 | 2020 | 381 | 0.430 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 31 | 0.430 |
Why?
|
| Insulin-Secreting Cells | 8 | 2022 | 177 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-akt | 11 | 2016 | 187 | 0.420 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 5 | 2012 | 64 | 0.420 |
Why?
|
| Doxorubicin | 1 | 2013 | 99 | 0.420 |
Why?
|
| Cytokines | 5 | 2018 | 911 | 0.410 |
Why?
|
| Endothelium, Vascular | 2 | 2021 | 171 | 0.400 |
Why?
|
| Glucagon | 2 | 2023 | 34 | 0.390 |
Why?
|
| Hepatocytes | 6 | 2022 | 195 | 0.390 |
Why?
|
| I-kappa B Proteins | 1 | 2012 | 38 | 0.390 |
Why?
|
| Vasculitis | 1 | 2012 | 51 | 0.380 |
Why?
|
| PPAR alpha | 3 | 2014 | 29 | 0.380 |
Why?
|
| Adipocytes, Brown | 4 | 2022 | 45 | 0.380 |
Why?
|
| Mice, Obese | 8 | 2023 | 79 | 0.380 |
Why?
|
| Heart Ventricles | 1 | 2013 | 251 | 0.380 |
Why?
|
| Mitochondrial Proteins | 4 | 2019 | 99 | 0.370 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 5 | 2013 | 11 | 0.370 |
Why?
|
| Osteoblasts | 5 | 2016 | 205 | 0.370 |
Why?
|
| Gene Deletion | 7 | 2015 | 297 | 0.360 |
Why?
|
| Longevity | 1 | 2012 | 112 | 0.360 |
Why?
|
| Glucose Tolerance Test | 12 | 2020 | 98 | 0.360 |
Why?
|
| Fibroblast Growth Factors | 4 | 2020 | 63 | 0.360 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2021 | 35 | 0.350 |
Why?
|
| Weight Loss | 1 | 2013 | 264 | 0.350 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2023 | 325 | 0.350 |
Why?
|
| Oxygen Consumption | 5 | 2019 | 203 | 0.340 |
Why?
|
| Phosphatidylinositol 3-Kinases | 5 | 2018 | 168 | 0.340 |
Why?
|
| Protein Kinase C | 4 | 2010 | 98 | 0.340 |
Why?
|
| Lipids | 9 | 2021 | 306 | 0.340 |
Why?
|
| Diet | 7 | 2018 | 637 | 0.340 |
Why?
|
| Diabetic Angiopathies | 1 | 2009 | 24 | 0.330 |
Why?
|
| Acyl Coenzyme A | 3 | 2006 | 9 | 0.330 |
Why?
|
| Gene Expression | 11 | 2021 | 807 | 0.320 |
Why?
|
| Muscle Proteins | 4 | 2019 | 110 | 0.320 |
Why?
|
| Hypothalamus | 4 | 2021 | 119 | 0.320 |
Why?
|
| DNA-Binding Proteins | 5 | 2016 | 1136 | 0.310 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 4 | 2017 | 123 | 0.310 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2017 | 155 | 0.300 |
Why?
|
| Uncoupling Protein 1 | 5 | 2019 | 47 | 0.300 |
Why?
|
| Animal Feed | 2 | 2020 | 16 | 0.300 |
Why?
|
| Glucose Transporter Type 4 | 6 | 2021 | 57 | 0.300 |
Why?
|
| Fatty Acid Synthases | 4 | 2023 | 22 | 0.290 |
Why?
|
| Triglycerides | 8 | 2020 | 242 | 0.290 |
Why?
|
| Circadian Rhythm | 3 | 2018 | 371 | 0.290 |
Why?
|
| Forkhead Box Protein O1 | 4 | 2021 | 16 | 0.290 |
Why?
|
| Ventricular Remodeling | 1 | 2007 | 80 | 0.280 |
Why?
|
| Antigens, CD | 4 | 2020 | 344 | 0.270 |
Why?
|
| Blotting, Western | 6 | 2016 | 594 | 0.270 |
Why?
|
| Cell Line | 8 | 2020 | 2018 | 0.270 |
Why?
|
| Cell Adhesion Molecules | 3 | 2015 | 88 | 0.260 |
Why?
|
| MAP Kinase Signaling System | 5 | 2014 | 201 | 0.260 |
Why?
|
| Isoenzymes | 3 | 2007 | 132 | 0.260 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2020 | 419 | 0.250 |
Why?
|
| Female | 31 | 2022 | 31229 | 0.250 |
Why?
|
| Humans | 40 | 2024 | 60093 | 0.250 |
Why?
|
| Hypoglycemic Agents | 4 | 2020 | 209 | 0.250 |
Why?
|
| Sterol Esterase | 1 | 2005 | 6 | 0.240 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2006 | 348 | 0.240 |
Why?
|
| DNA Glycosylases | 1 | 2024 | 16 | 0.240 |
Why?
|
| Vesicular Transport Proteins | 3 | 2021 | 105 | 0.240 |
Why?
|
| Gluconeogenesis | 6 | 2023 | 15 | 0.230 |
Why?
|
| Receptors, Interferon | 1 | 2024 | 18 | 0.230 |
Why?
|
| Activating Transcription Factor 4 | 2 | 2018 | 8 | 0.230 |
Why?
|
| Cell Membrane | 5 | 2021 | 492 | 0.230 |
Why?
|
| DNA, Mitochondrial | 1 | 2024 | 78 | 0.230 |
Why?
|
| Thiazolidinediones | 2 | 2007 | 52 | 0.230 |
Why?
|
| Protein Tyrosine Phosphatases | 5 | 2009 | 57 | 0.220 |
Why?
|
| Ion Channels | 3 | 2016 | 88 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 5 | 2011 | 417 | 0.220 |
Why?
|
| Unfolded Protein Response | 2 | 2018 | 55 | 0.220 |
Why?
|
| Sympathetic Nervous System | 2 | 2017 | 33 | 0.220 |
Why?
|
| Diabetes Mellitus | 2 | 2018 | 537 | 0.220 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2023 | 13 | 0.210 |
Why?
|
| Fatty Acids, Nonesterified | 6 | 2017 | 55 | 0.210 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 122 | 0.210 |
Why?
|
| MicroRNAs | 3 | 2014 | 620 | 0.210 |
Why?
|
| Thiazoles | 1 | 2003 | 46 | 0.210 |
Why?
|
| Glycoproteins | 2 | 2017 | 194 | 0.210 |
Why?
|
| Cell Differentiation | 7 | 2021 | 1297 | 0.210 |
Why?
|
| CRISPR-Cas Systems | 3 | 2021 | 332 | 0.210 |
Why?
|
| DNA Damage | 1 | 2024 | 281 | 0.200 |
Why?
|
| Liver Cirrhosis | 1 | 2024 | 160 | 0.200 |
Why?
|
| Lipoprotein Lipase | 3 | 2008 | 15 | 0.200 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2022 | 22 | 0.200 |
Why?
|
| Insulin Receptor Substrate Proteins | 5 | 2012 | 58 | 0.200 |
Why?
|
| Organ Specificity | 6 | 2010 | 181 | 0.190 |
Why?
|
| Adipocytes, White | 3 | 2021 | 27 | 0.190 |
Why?
|
| Mitochondria, Muscle | 1 | 2021 | 13 | 0.190 |
Why?
|
| Receptor for Advanced Glycation End Products | 2 | 2019 | 19 | 0.190 |
Why?
|
| Infusions, Intravenous | 3 | 2009 | 170 | 0.190 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2013 | 83 | 0.190 |
Why?
|
| Growth Hormone | 2 | 2016 | 19 | 0.190 |
Why?
|
| Osteocalcin | 3 | 2009 | 48 | 0.180 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2015 | 42 | 0.180 |
Why?
|
| Iridovirus | 1 | 2020 | 4 | 0.180 |
Why?
|
| Gene Knockout Techniques | 2 | 2022 | 88 | 0.180 |
Why?
|
| Nucleus Accumbens | 1 | 2021 | 42 | 0.180 |
Why?
|
| Adipogenesis | 4 | 2017 | 71 | 0.180 |
Why?
|
| Glycolysis | 4 | 2016 | 54 | 0.180 |
Why?
|
| Lipolysis | 5 | 2019 | 47 | 0.180 |
Why?
|
| Lactation | 1 | 2021 | 72 | 0.180 |
Why?
|
| Lipodystrophy | 3 | 2016 | 11 | 0.170 |
Why?
|
| Arrestins | 1 | 2020 | 6 | 0.170 |
Why?
|
| Mutation, Missense | 2 | 2016 | 180 | 0.170 |
Why?
|
| GTP Phosphohydrolases | 2 | 2011 | 59 | 0.170 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2019 | 86 | 0.170 |
Why?
|
| Myostatin | 1 | 2020 | 13 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 57 | 0.170 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2020 | 83 | 0.170 |
Why?
|
| NAD | 1 | 2020 | 48 | 0.170 |
Why?
|
| Endothelial Cells | 1 | 2021 | 177 | 0.170 |
Why?
|
| Oxidation-Reduction | 6 | 2020 | 305 | 0.170 |
Why?
|
| Intra-Abdominal Fat | 2 | 2019 | 34 | 0.170 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2020 | 64 | 0.170 |
Why?
|
| Metabolic Syndrome | 2 | 2013 | 149 | 0.170 |
Why?
|
| Forkhead Transcription Factors | 3 | 2013 | 118 | 0.160 |
Why?
|
| Hippocampus | 1 | 2021 | 243 | 0.160 |
Why?
|
| Muscular Atrophy | 1 | 2019 | 26 | 0.160 |
Why?
|
| Subcutaneous Tissue | 1 | 2019 | 14 | 0.160 |
Why?
|
| Calorimetry, Indirect | 3 | 2020 | 32 | 0.160 |
Why?
|
| Phenotype | 7 | 2020 | 1157 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 8 | 2016 | 524 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 4 | 2013 | 115 | 0.160 |
Why?
|
| Fasting | 3 | 2019 | 51 | 0.160 |
Why?
|
| Hyperphagia | 3 | 2019 | 17 | 0.160 |
Why?
|
| Glucagon-Like Peptide 1 | 2 | 2016 | 23 | 0.160 |
Why?
|
| Stearoyl-CoA Desaturase | 1 | 2018 | 9 | 0.160 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2019 | 79 | 0.160 |
Why?
|
| Neurons | 4 | 2021 | 863 | 0.150 |
Why?
|
| Estrogen Receptor alpha | 1 | 2018 | 47 | 0.150 |
Why?
|
| Body Temperature Regulation | 1 | 2018 | 20 | 0.150 |
Why?
|
| Acetyl-CoA C-Acetyltransferase | 1 | 2018 | 1 | 0.150 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2018 | 1 | 0.150 |
Why?
|
| Adaptation, Physiological | 2 | 2012 | 118 | 0.150 |
Why?
|
| Muscles | 2 | 2013 | 171 | 0.150 |
Why?
|
| Tristetraprolin | 1 | 2018 | 7 | 0.150 |
Why?
|
| RNA, Messenger | 4 | 2018 | 1469 | 0.150 |
Why?
|
| Gene Targeting | 1 | 2018 | 82 | 0.150 |
Why?
|
| Receptor, Melatonin, MT1 | 1 | 2018 | 5 | 0.150 |
Why?
|
| Muscle Cells | 1 | 2018 | 27 | 0.150 |
Why?
|
| Receptors, Estrogen | 1 | 2018 | 125 | 0.150 |
Why?
|
| Interleukin-13 | 1 | 2018 | 35 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2019 | 198 | 0.150 |
Why?
|
| Glucose Transporter Type 1 | 3 | 2013 | 51 | 0.150 |
Why?
|
| Diarylheptanoids | 1 | 2017 | 1 | 0.140 |
Why?
|
| Neuregulins | 1 | 2017 | 8 | 0.140 |
Why?
|
| Anti-Obesity Agents | 1 | 2017 | 13 | 0.140 |
Why?
|
| Oxidative Stress | 2 | 2024 | 282 | 0.140 |
Why?
|
| src-Family Kinases | 1 | 2017 | 60 | 0.140 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 71 | 0.140 |
Why?
|
| Palmitates | 3 | 2023 | 21 | 0.140 |
Why?
|
| Bone and Bones | 2 | 2009 | 156 | 0.140 |
Why?
|
| Stem Cells | 1 | 2019 | 258 | 0.140 |
Why?
|
| Enzyme Activation | 6 | 2017 | 356 | 0.140 |
Why?
|
| Receptors, Interleukin-10 | 1 | 2016 | 3 | 0.140 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2016 | 4 | 0.140 |
Why?
|
| Polyphenols | 1 | 2017 | 56 | 0.140 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 151 | 0.140 |
Why?
|
| Membrane Proteins | 3 | 2016 | 845 | 0.130 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 34 | 0.130 |
Why?
|
| Receptors, Somatotropin | 1 | 2016 | 3 | 0.130 |
Why?
|
| Lipid Droplets | 1 | 2016 | 29 | 0.130 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 70 | 0.130 |
Why?
|
| Phosphoproteins | 4 | 2008 | 213 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2016 | 12 | 0.130 |
Why?
|
| Fructose | 1 | 2016 | 40 | 0.130 |
Why?
|
| Betaine | 1 | 2016 | 10 | 0.130 |
Why?
|
| Fatty Acid-Binding Proteins | 4 | 2012 | 21 | 0.130 |
Why?
|
| Physical Conditioning, Animal | 2 | 2013 | 38 | 0.130 |
Why?
|
| Weight Gain | 4 | 2022 | 162 | 0.130 |
Why?
|
| Antigens, Neoplasm | 1 | 2016 | 136 | 0.130 |
Why?
|
| Mitochondria | 5 | 2024 | 337 | 0.130 |
Why?
|
| Skin | 1 | 2018 | 356 | 0.130 |
Why?
|
| Alternative Splicing | 1 | 2016 | 120 | 0.130 |
Why?
|
| Nuclear Proteins | 3 | 2016 | 760 | 0.130 |
Why?
|
| Fatty Acid Transport Proteins | 2 | 2006 | 7 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 102 | 0.120 |
Why?
|
| Cell Nucleus | 1 | 2018 | 604 | 0.120 |
Why?
|
| Proteins | 5 | 2016 | 743 | 0.120 |
Why?
|
| Endoplasmic Reticulum | 3 | 2012 | 168 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 277 | 0.120 |
Why?
|
| Obesity, Morbid | 1 | 2016 | 96 | 0.120 |
Why?
|
| Mice, Mutant Strains | 4 | 2016 | 304 | 0.110 |
Why?
|
| Prediabetic State | 1 | 2015 | 52 | 0.110 |
Why?
|
| RNA | 3 | 2013 | 405 | 0.110 |
Why?
|
| NF-kappa B | 2 | 2021 | 462 | 0.110 |
Why?
|
| Sphingolipids | 2 | 2010 | 23 | 0.110 |
Why?
|
| Superoxide Dismutase | 2 | 2013 | 214 | 0.110 |
Why?
|
| Brain | 2 | 2015 | 1493 | 0.110 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2013 | 38 | 0.110 |
Why?
|
| Triiodothyronine | 1 | 2013 | 26 | 0.110 |
Why?
|
| Pregnancy | 1 | 2021 | 2359 | 0.110 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2013 | 19 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2016 | 388 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 477 | 0.110 |
Why?
|
| Cell Cycle Proteins | 4 | 2010 | 387 | 0.110 |
Why?
|
| Cell Proliferation | 3 | 2013 | 943 | 0.110 |
Why?
|
| Huntington Disease | 1 | 2015 | 146 | 0.110 |
Why?
|
| Receptors, Immunologic | 1 | 2014 | 177 | 0.110 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2013 | 74 | 0.110 |
Why?
|
| CD40 Antigens | 1 | 2013 | 60 | 0.100 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2004 | 144 | 0.100 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 262 | 0.100 |
Why?
|
| Interleukins | 1 | 2013 | 78 | 0.100 |
Why?
|
| Acetyl Coenzyme A | 2 | 2023 | 22 | 0.100 |
Why?
|
| Adrenal Glands | 1 | 2013 | 30 | 0.100 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2019 | 125 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2012 | 35 | 0.100 |
Why?
|
| Creatine Kinase | 2 | 2009 | 41 | 0.100 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2012 | 17 | 0.100 |
Why?
|
| Serotonin | 1 | 2012 | 63 | 0.100 |
Why?
|
| Models, Biological | 3 | 2013 | 1143 | 0.100 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2012 | 26 | 0.100 |
Why?
|
| Calmodulin | 1 | 2012 | 19 | 0.100 |
Why?
|
| Neuroblastoma | 1 | 2013 | 85 | 0.100 |
Why?
|
| Survival Analysis | 1 | 2013 | 558 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 116 | 0.100 |
Why?
|
| Glycogen | 3 | 2006 | 47 | 0.100 |
Why?
|
| Flow Cytometry | 2 | 2013 | 636 | 0.100 |
Why?
|
| Mitochondria, Heart | 1 | 2011 | 13 | 0.090 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2013 | 168 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2016 | 218 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2012 | 68 | 0.090 |
Why?
|
| Receptor, IGF Type 1 | 2 | 2021 | 30 | 0.090 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2012 | 61 | 0.090 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2011 | 10 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2013 | 460 | 0.090 |
Why?
|
| Gastrointestinal Tract | 1 | 2012 | 168 | 0.090 |
Why?
|
| Recombinant Proteins | 4 | 2020 | 697 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 855 | 0.090 |
Why?
|
| Pyrrolidines | 1 | 2010 | 12 | 0.090 |
Why?
|
| Glucosyltransferases | 1 | 2010 | 13 | 0.090 |
Why?
|
| Pituitary Gland | 1 | 2010 | 49 | 0.080 |
Why?
|
| Adiponectin | 3 | 2004 | 34 | 0.080 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 296 | 0.080 |
Why?
|
| Thyroid Gland | 1 | 2010 | 78 | 0.080 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2010 | 88 | 0.080 |
Why?
|
| Heterozygote | 1 | 2009 | 166 | 0.080 |
Why?
|
| Receptor, Melanocortin, Type 3 | 1 | 2008 | 1 | 0.080 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2008 | 5 | 0.080 |
Why?
|
| Appetite Regulation | 1 | 2008 | 8 | 0.080 |
Why?
|
| Appetite | 1 | 2008 | 16 | 0.080 |
Why?
|
| Regional Blood Flow | 1 | 2009 | 108 | 0.080 |
Why?
|
| Immunity, Innate | 1 | 2015 | 766 | 0.080 |
Why?
|
| Transgenes | 2 | 2013 | 176 | 0.080 |
Why?
|
| Islets of Langerhans | 4 | 2015 | 267 | 0.080 |
Why?
|
| Protein Kinase C-theta | 2 | 2007 | 16 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 299 | 0.080 |
Why?
|
| Thioredoxins | 1 | 2008 | 15 | 0.070 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2007 | 4 | 0.070 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2007 | 4 | 0.070 |
Why?
|
| Phlorhizin | 1 | 2007 | 2 | 0.070 |
Why?
|
| Disulfides | 1 | 2008 | 63 | 0.070 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2007 | 12 | 0.070 |
Why?
|
| RAW 264.7 Cells | 2 | 2018 | 48 | 0.070 |
Why?
|
| Cell Size | 3 | 2018 | 41 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 497 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 182 | 0.070 |
Why?
|
| Organ Size | 3 | 2018 | 165 | 0.070 |
Why?
|
| Integrin beta1 | 2 | 2018 | 28 | 0.070 |
Why?
|
| Age of Onset | 1 | 2007 | 171 | 0.070 |
Why?
|
| Genotype | 3 | 2020 | 643 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2007 | 122 | 0.070 |
Why?
|
| Glucose-6-Phosphate | 1 | 2006 | 1 | 0.070 |
Why?
|
| Multiprotein Complexes | 2 | 2021 | 154 | 0.070 |
Why?
|
| Kupffer Cells | 2 | 2018 | 42 | 0.070 |
Why?
|
| Immediate-Early Proteins | 1 | 2006 | 44 | 0.070 |
Why?
|
| Gene Editing | 2 | 2021 | 301 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2012 | 820 | 0.060 |
Why?
|
| Fibroblasts | 3 | 2015 | 370 | 0.060 |
Why?
|
| Phosphotyrosine | 3 | 2017 | 23 | 0.060 |
Why?
|
| Adenosine Triphosphate | 2 | 2022 | 289 | 0.060 |
Why?
|
| Dependovirus | 1 | 2012 | 659 | 0.060 |
Why?
|
| Oxidative Phosphorylation | 2 | 2019 | 35 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2010 | 604 | 0.060 |
Why?
|
| 3T3-L1 Cells | 2 | 2017 | 83 | 0.060 |
Why?
|
| Caveolins | 1 | 2005 | 6 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2006 | 201 | 0.060 |
Why?
|
| Rats | 3 | 2020 | 1914 | 0.060 |
Why?
|
| Glucose-6-Phosphatase | 2 | 2016 | 15 | 0.060 |
Why?
|
| Eating | 3 | 2010 | 139 | 0.060 |
Why?
|
| Multienzyme Complexes | 2 | 2020 | 77 | 0.060 |
Why?
|
| Sex Factors | 2 | 2022 | 970 | 0.060 |
Why?
|
| Patch-Clamp Techniques | 1 | 2004 | 126 | 0.060 |
Why?
|
| HLA Antigens | 1 | 2004 | 60 | 0.060 |
Why?
|
| Immunoblotting | 3 | 2010 | 190 | 0.060 |
Why?
|
| Cholesterol | 2 | 2017 | 255 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2004 | 82 | 0.050 |
Why?
|
| 1-Acylglycerophosphocholine O-Acyltransferase | 1 | 2023 | 1 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2017 | 94 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2004 | 253 | 0.050 |
Why?
|
| DNA Repair | 1 | 2024 | 233 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2014 | 193 | 0.050 |
Why?
|
| Adrenergic Agents | 1 | 2022 | 16 | 0.050 |
Why?
|
| Fecal Microbiota Transplantation | 1 | 2022 | 17 | 0.050 |
Why?
|
| Phospholipids | 1 | 2023 | 80 | 0.050 |
Why?
|
| Fatty Acid Synthase, Type I | 2 | 2014 | 5 | 0.050 |
Why?
|
| Malonyl Coenzyme A | 1 | 2022 | 11 | 0.050 |
Why?
|
| Diabetes Mellitus, Lipoatrophic | 1 | 2002 | 1 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2014 | 305 | 0.050 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2022 | 17 | 0.050 |
Why?
|
| Adrenalectomy | 1 | 2002 | 24 | 0.050 |
Why?
|
| Wakefulness | 2 | 2015 | 41 | 0.050 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2002 | 36 | 0.050 |
Why?
|
| Datasets as Topic | 1 | 2022 | 21 | 0.050 |
Why?
|
| Gene Knock-In Techniques | 1 | 2022 | 34 | 0.050 |
Why?
|
| Mutation | 4 | 2013 | 2466 | 0.050 |
Why?
|
| Adult Stem Cells | 1 | 2021 | 28 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2004 | 522 | 0.050 |
Why?
|
| Heart Failure | 1 | 2009 | 868 | 0.050 |
Why?
|
| Fats | 1 | 2021 | 18 | 0.050 |
Why?
|
| Subcutaneous Fat | 1 | 2021 | 47 | 0.050 |
Why?
|
| Feeding Behavior | 3 | 2010 | 314 | 0.050 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2021 | 9 | 0.050 |
Why?
|
| Myoblasts, Skeletal | 1 | 2021 | 12 | 0.050 |
Why?
|
| Iridoviridae | 1 | 2020 | 1 | 0.050 |
Why?
|
| Lipase | 2 | 2012 | 49 | 0.050 |
Why?
|
| Carbohydrate Metabolism | 1 | 2021 | 48 | 0.050 |
Why?
|
| Exocytosis | 1 | 2021 | 59 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2013 | 48 | 0.040 |
Why?
|
| Streptozocin | 1 | 2020 | 21 | 0.040 |
Why?
|
| Nitric Oxide | 1 | 2021 | 144 | 0.040 |
Why?
|
| Insulins | 1 | 2020 | 15 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 179 | 0.040 |
Why?
|
| Astrocytes | 1 | 2021 | 116 | 0.040 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2020 | 18 | 0.040 |
Why?
|
| Animal Husbandry | 1 | 2020 | 9 | 0.040 |
Why?
|
| Growth Differentiation Factors | 1 | 2020 | 3 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2016 | 252 | 0.040 |
Why?
|
| Adult | 4 | 2019 | 15980 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2021 | 274 | 0.040 |
Why?
|
| COS Cells | 2 | 2009 | 175 | 0.040 |
Why?
|
| Protein Transport | 1 | 2021 | 398 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 157 | 0.040 |
Why?
|
| Cytosol | 1 | 2020 | 170 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 344 | 0.040 |
Why?
|
| Autophagy | 1 | 2021 | 208 | 0.040 |
Why?
|
| Zinc Fingers | 1 | 2019 | 96 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2019 | 89 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2019 | 236 | 0.040 |
Why?
|
| Temperature | 1 | 2020 | 298 | 0.040 |
Why?
|
| Hair Follicle | 1 | 2018 | 29 | 0.040 |
Why?
|
| Hypertension | 1 | 2004 | 601 | 0.040 |
Why?
|
| Thinness | 1 | 2018 | 41 | 0.040 |
Why?
|
| Protein Isoforms | 2 | 2013 | 195 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2018 | 62 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2018 | 286 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2020 | 366 | 0.040 |
Why?
|
| I-kappa B Kinase | 1 | 2018 | 48 | 0.040 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2018 | 136 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2018 | 49 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2018 | 243 | 0.040 |
Why?
|
| Plasmids | 1 | 2018 | 283 | 0.040 |
Why?
|
| Locomotion | 1 | 2018 | 111 | 0.040 |
Why?
|
| Neuropeptide Y | 1 | 2017 | 13 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2018 | 92 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2017 | 54 | 0.040 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 1 | 2018 | 92 | 0.040 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2017 | 36 | 0.040 |
Why?
|
| Membrane Microdomains | 1 | 2017 | 48 | 0.040 |
Why?
|
| Protein Domains | 1 | 2017 | 141 | 0.030 |
Why?
|
| Osteocytes | 1 | 2016 | 12 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2017 | 143 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2018 | 854 | 0.030 |
Why?
|
| Agouti-Related Protein | 1 | 2016 | 4 | 0.030 |
Why?
|
| Enkephalins | 1 | 2016 | 15 | 0.030 |
Why?
|
| Proprotein Convertase 1 | 1 | 2016 | 8 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2016 | 18 | 0.030 |
Why?
|
| Interleukin-33 | 1 | 2016 | 18 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 2016 | 39 | 0.030 |
Why?
|
| Capillaries | 1 | 2016 | 30 | 0.030 |
Why?
|
| Epididymis | 1 | 2016 | 27 | 0.030 |
Why?
|
| Calcium Channels, L-Type | 1 | 2015 | 25 | 0.030 |
Why?
|
| Protein Precursors | 1 | 2016 | 74 | 0.030 |
Why?
|
| Biological Transport | 1 | 2016 | 287 | 0.030 |
Why?
|
| Biomarkers | 2 | 2011 | 1212 | 0.030 |
Why?
|
| Myogenic Regulatory Factor 5 | 1 | 2015 | 16 | 0.030 |
Why?
|
| Tamoxifen | 1 | 2015 | 34 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2016 | 148 | 0.030 |
Why?
|
| Embryo, Mammalian | 2 | 2008 | 161 | 0.030 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2015 | 4 | 0.030 |
Why?
|
| Protein Phosphatase 2C | 1 | 2015 | 4 | 0.030 |
Why?
|
| Diet, Fat-Restricted | 1 | 2015 | 36 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 75 | 0.030 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2014 | 4 | 0.030 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2014 | 2 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 498 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2014 | 64 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 332 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2014 | 37 | 0.030 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2004 | 43 | 0.030 |
Why?
|
| Munc18 Proteins | 2 | 2004 | 12 | 0.030 |
Why?
|
| Qa-SNARE Proteins | 2 | 2004 | 18 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 2007 | 876 | 0.030 |
Why?
|
| Ribonuclease III | 1 | 2014 | 81 | 0.030 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2013 | 30 | 0.030 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 78 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2014 | 87 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 59 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2016 | 249 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2013 | 51 | 0.030 |
Why?
|
| Thyroid Hormones | 1 | 2013 | 74 | 0.030 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2013 | 8 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2013 | 13 | 0.030 |
Why?
|
| Receptors, Serotonin, 5-HT2 | 1 | 2012 | 2 | 0.030 |
Why?
|
| Glucose Transporter Type 2 | 1 | 2012 | 3 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2013 | 75 | 0.030 |
Why?
|
| NADPH Oxidases | 1 | 2013 | 64 | 0.030 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2013 | 70 | 0.030 |
Why?
|
| Peptides | 1 | 2016 | 550 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 136 | 0.030 |
Why?
|
| Mitochondria, Liver | 1 | 2012 | 11 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2012 | 185 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2013 | 252 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2012 | 119 | 0.020 |
Why?
|
| Polyribosomes | 1 | 2012 | 14 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 483 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 584 | 0.020 |
Why?
|
| RNA, Antisense | 1 | 2012 | 49 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 448 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 272 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2012 | 365 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2012 | 74 | 0.020 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 2011 | 4 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 677 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 558 | 0.020 |
Why?
|
| Peroxidases | 1 | 2010 | 7 | 0.020 |
Why?
|
| Lysophospholipids | 1 | 2010 | 22 | 0.020 |
Why?
|
| Sphingosine | 1 | 2010 | 22 | 0.020 |
Why?
|
| Hypoxia | 1 | 2012 | 109 | 0.020 |
Why?
|
| Ataxia Telangiectasia | 1 | 2010 | 12 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 928 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2011 | 113 | 0.020 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2010 | 11 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 168 | 0.020 |
Why?
|
| Body Temperature | 1 | 2009 | 43 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 64 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2010 | 64 | 0.020 |
Why?
|
| Integrases | 1 | 2010 | 36 | 0.020 |
Why?
|
| Phenylephrine | 1 | 2009 | 15 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2009 | 105 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 202 | 0.020 |
Why?
|
| Isoproterenol | 1 | 2009 | 34 | 0.020 |
Why?
|
| Protein Denaturation | 1 | 2009 | 66 | 0.020 |
Why?
|
| Clonidine | 1 | 2009 | 24 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2010 | 114 | 0.020 |
Why?
|
| Bone Remodeling | 1 | 2009 | 25 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2009 | 7 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2009 | 15 | 0.020 |
Why?
|
| Binding Sites | 1 | 2012 | 872 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2009 | 73 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 292 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 1307 | 0.020 |
Why?
|
| Alleles | 1 | 2010 | 423 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2008 | 8 | 0.020 |
Why?
|
| Exons | 1 | 2010 | 193 | 0.020 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 14 | 0.020 |
Why?
|
| ARNTL Transcription Factors | 1 | 2008 | 25 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2008 | 25 | 0.020 |
Why?
|
| Glucokinase | 1 | 2008 | 3 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2010 | 139 | 0.020 |
Why?
|
| Middle Aged | 2 | 2016 | 16540 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 576 | 0.020 |
Why?
|
| Pyruvate Kinase | 1 | 2008 | 11 | 0.020 |
Why?
|
| Calorimetry | 1 | 2008 | 40 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 1383 | 0.020 |
Why?
|
| Period Circadian Proteins | 1 | 2008 | 71 | 0.020 |
Why?
|
| Antioxidants | 1 | 2010 | 248 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 1054 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 454 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2008 | 89 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 1973 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2008 | 56 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2010 | 346 | 0.020 |
Why?
|
| Reference Values | 1 | 2008 | 322 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 124 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2477 | 0.020 |
Why?
|
| Insulin Antagonists | 1 | 2007 | 3 | 0.020 |
Why?
|
| Endotoxemia | 1 | 2007 | 11 | 0.020 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2007 | 3 | 0.020 |
Why?
|
| Time Factors | 2 | 2007 | 3619 | 0.020 |
Why?
|
| Lactates | 1 | 2007 | 28 | 0.020 |
Why?
|
| Transfection | 1 | 2009 | 676 | 0.020 |
Why?
|
| Calibration | 1 | 2007 | 64 | 0.020 |
Why?
|
| Uncoupling Protein 3 | 1 | 2007 | 3 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2007 | 41 | 0.020 |
Why?
|
| Glycerol | 1 | 2007 | 31 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2007 | 37 | 0.020 |
Why?
|
| Hormones | 1 | 2007 | 56 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 661 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 253 | 0.020 |
Why?
|
| Lactic Acid | 1 | 2007 | 70 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2007 | 66 | 0.020 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2006 | 3 | 0.020 |
Why?
|
| Models, Animal | 1 | 2007 | 222 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2006 | 16 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2007 | 170 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2006 | 25 | 0.020 |
Why?
|
| Adenylate Kinase | 1 | 2006 | 15 | 0.020 |
Why?
|
| Amino Acids | 1 | 2007 | 139 | 0.020 |
Why?
|
| Hexokinase | 1 | 2005 | 11 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2007 | 309 | 0.020 |
Why?
|
| Deoxyglucose | 1 | 2005 | 31 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2005 | 26 | 0.020 |
Why?
|
| Age Factors | 1 | 2010 | 1526 | 0.020 |
Why?
|
| Motor Activity | 1 | 2008 | 343 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 2005 | 49 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2005 | 41 | 0.020 |
Why?
|
| Perfusion | 1 | 2005 | 77 | 0.020 |
Why?
|
| rho-Associated Kinases | 1 | 2005 | 11 | 0.020 |
Why?
|
| Caveolin 3 | 1 | 2005 | 3 | 0.020 |
Why?
|
| Tetracyclines | 1 | 2004 | 6 | 0.010 |
Why?
|
| Cricetinae | 1 | 2005 | 376 | 0.010 |
Why?
|
| Body Weights and Measures | 1 | 2004 | 34 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 79 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 5264 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 148 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2003 | 52 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2003 | 51 | 0.010 |
Why?
|
| Tyrosine | 1 | 2004 | 93 | 0.010 |
Why?
|
| Species Specificity | 1 | 2004 | 334 | 0.010 |
Why?
|
| Alanine | 1 | 2003 | 46 | 0.010 |
Why?
|
| Tetracycline | 1 | 2003 | 20 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2006 | 379 | 0.010 |
Why?
|
| Serine | 1 | 2003 | 83 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2007 | 854 | 0.010 |
Why?
|
| Diglycerides | 1 | 2002 | 22 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2002 | 179 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 805 | 0.010 |
Why?
|
| Energy Intake | 1 | 2002 | 213 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 736 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 13581 | 0.010 |
Why?
|
| Neoplasms | 1 | 2008 | 1261 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 735 | 0.010 |
Why?
|